The brief
- ARIA is a £800M+ UK fund for moonshot research, modeled after DARPA.
- Precision Neurotechnologies commits £69M over four years for 19 teams on circuit-level brain interfaces.
- Targets Alzheimer's, epilepsy, addiction and depression via cell-type-specific brain modulation.
Technical approach
Circuit targeting
Cell-type-specific stimulation
Research to target specific neural circuits and cell types with precision.
Hybrid design
Biology with electronics
Teams combine hardware, bioinspired interfaces and synthetic biology approaches.
Minimally invasive
Non-invasive and remote methods
Workstreams cover non-invasive, remote, biological and adoption approaches.
